FHIR IG analytics| Package | uz.dhp.integrations |
| Resource Type | Questionnaire |
| Id | Questionnaire-CVDRiskScreeningQuestionnaire.json |
| FHIR Version | R5 |
| Source | https://build.fhir.org/ig/uzinfocom-org/digital-health-integration/Questionnaire-CVDRiskScreeningQuestionnaire.html |
| URL | https://dhp.uz/fhir/integrations/Questionnaire/CVDRiskScreeningQuestionnaire |
| Version | 0.11.1 |
| Status | draft |
| Date | 2026-10-15T07:49:44+00:00 |
| Name | CVDRiskScreeningQuestionnaire |
| Title | Yurak-qon tomir kasalliklari xavfini erta aniqlash skriningi |
| Description | DMed qabulida bemor uchun so'rovnoma: yosh, jins, vazn, bo'y, TVI, arterial bosim va tamaki mahsulotlari iste'moli. |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
English
Generated Narrative: Questionnaire CVDRiskScreeningQuestionnaire
Language: uz
Profile: UZ Core Questionnaire version: 0.11.1
| LinkID | Text | Cardinality | Type | Flags | Description & Constraints |
|---|---|---|---|---|---|
  CVDRiskScreeningQuestionnaire | DMed qabulida bemor uchun so'rovnoma: yosh, jins, vazn, bo'y, TVI, arterial bosim va tamaki mahsulotlari iste'moli. | Questionnaire | https://dhp.uz/fhir/integrations/Questionnaire/CVDRiskScreeningQuestionnaire#0.11.1 | ||
  age | Yosh | 1..1 | integer | ||
 sex | Jins | 1..1 | coding | Options: 4 options | |
 weight | Vazn | 1..1 | decimal | ||
| height | Bo'y | 1..1 | decimal | ||
| bmi | Tana vazni indeksi | 0..1 | decimal |  | |
| systolic-bp | Sistolik bosim | 1..1 | decimal | ||
| diastolic-bp | Diastolik bosim | 1..1 | decimal | ||
| tobacco-use | Tamaki mahsulotlarini iste'mol qilish | 1..1 | coding | Options: 3 options | |
  cvd-risk-result | Yurak-qon tomir kasalliklari xavfini baholash | 0..1 | group | ||
 cvd-risk-score | 10 yillik xavf (%) | 0..1 | integer | | |
| cvd-risk-category | Xavf darajasi | 0..1 | coding | | Options: 5 options |
 recommendation-low | Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv 12 oydan keyin o'tkaziladi. | 0..1 | display | Enable When: cvd-risk-score < 5 | |
| recommendation-moderate | Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv har uch oyda o'tkaziladi (arterial bosimning maqsadli darajasiga erishilganda - takroriy tekshiruvlar har 6-9 oyda amalga oshiriladi). Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'zlar ko'ruvi, EKG - 2 yilda 1 marta yoki ko'rsatma bo'yicha. | 0..1 | display | Enable When:
| |
| recommendation-medium | Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta. | 0..1 | display | Enable When:
| |
| recommendation-high | Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Lipid spektri va qondagi kreatinin darajasi hamda koptokchali filtratsiya tezligi (KFT) hisobi reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta. | 0..1 | display | Enable When: cvd-risk-score >= 20 | |
| Documentation for this format | |||||
Options Sets
Answer options for sex
Answer options for tobacco-use
Answer options for cvd-risk-category
Russian
Сгенерированный нарратив: Questionnaire CVDRiskScreeningQuestionnaire
Язык: uz
Профиль: UZ Core Questionnaire версия: 0.11.1
| LinkID | Текст | Кардинальность | Тип | Флаги | Описание и ограничения |
|---|---|---|---|---|---|
| CVDRiskScreeningQuestionnaire | DMed qabulida bemor uchun so'rovnoma: yosh, jins, vazn, bo'y, TVI, arterial bosim va tamaki mahsulotlari iste'moli. | Questionnaire | https://dhp.uz/fhir/integrations/Questionnaire/CVDRiskScreeningQuestionnaire#0.11.1 | ||
| age | Yosh | 1..1 | integer | ||
| sex | Jins | 1..1 | coding | Параметры: 4 options | |
| weight | Vazn | 1..1 | decimal | ||
| height | Bo'y | 1..1 | decimal | ||
| bmi | Tana vazni indeksi | 0..1 | decimal | | |
| systolic-bp | Sistolik bosim | 1..1 | decimal | ||
| diastolic-bp | Diastolik bosim | 1..1 | decimal | ||
| tobacco-use | Tamaki mahsulotlarini iste'mol qilish | 1..1 | coding | Параметры: 3 options | |
| cvd-risk-result | Yurak-qon tomir kasalliklari xavfini baholash | 0..1 | group | ||
| cvd-risk-score | 10 yillik xavf (%) | 0..1 | integer | | |
| cvd-risk-category | Xavf darajasi | 0..1 | coding | | Параметры: 5 options |
| recommendation-low | Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv 12 oydan keyin o'tkaziladi. | 0..1 | display | Включить когда: cvd-risk-score < 5 | |
| recommendation-moderate | Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv har uch oyda o'tkaziladi (arterial bosimning maqsadli darajasiga erishilganda - takroriy tekshiruvlar har 6-9 oyda amalga oshiriladi). Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'zlar ko'ruvi, EKG - 2 yilda 1 marta yoki ko'rsatma bo'yicha. | 0..1 | display | Включить когда:
| |
| recommendation-medium | Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta. | 0..1 | display | Включить когда:
| |
| recommendation-high | Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Lipid spektri va qondagi kreatinin darajasi hamda koptokchali filtratsiya tezligi (KFT) hisobi reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta. | 0..1 | display | Включить когда: cvd-risk-score >= 20 | |
| Документация для этого формата | |||||
Наборы параметров
Варианты ответов для sex
Варианты ответов для tobacco-use
Варианты ответов для cvd-risk-category
Uzbek
Yaratilgan tavsif: Questionnaire CVDRiskScreeningQuestionnaire
Til: uz
Profil: UZ Core Questionnaire versiya: 0.11.1
| LinkID | Matn | Kardinallik | Turi | Belgilar | Tavsif va cheklovlar |
|---|---|---|---|---|---|
| CVDRiskScreeningQuestionnaire | DMed qabulida bemor uchun so'rovnoma: yosh, jins, vazn, bo'y, TVI, arterial bosim va tamaki mahsulotlari iste'moli. | So'rovnoma | https://dhp.uz/fhir/integrations/Questionnaire/CVDRiskScreeningQuestionnaire#0.11.1 | ||
| age | Yosh | 1..1 | integer | ||
| sex | Jins | 1..1 | coding | Variantlar: 4 options | |
| weight | Vazn | 1..1 | decimal | ||
| height | Bo'y | 1..1 | decimal | ||
| bmi | Tana vazni indeksi | 0..1 | decimal | | |
| systolic-bp | Sistolik bosim | 1..1 | decimal | ||
| diastolic-bp | Diastolik bosim | 1..1 | decimal | ||
| tobacco-use | Tamaki mahsulotlarini iste'mol qilish | 1..1 | coding | Variantlar: 3 options | |
| cvd-risk-result | Yurak-qon tomir kasalliklari xavfini baholash | 0..1 | group | ||
| cvd-risk-score | 10 yillik xavf (%) | 0..1 | integer | | |
| cvd-risk-category | Xavf darajasi | 0..1 | coding | | Variantlar: 5 options |
| recommendation-low | Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv 12 oydan keyin o'tkaziladi. | 0..1 | display | Qachon yoqiladi: cvd-risk-score < 5 | |
| recommendation-moderate | Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv har uch oyda o'tkaziladi (arterial bosimning maqsadli darajasiga erishilganda - takroriy tekshiruvlar har 6-9 oyda amalga oshiriladi). Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'zlar ko'ruvi, EKG - 2 yilda 1 marta yoki ko'rsatma bo'yicha. | 0..1 | display | Qachon yoqiladi:
| |
| recommendation-medium | Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta. | 0..1 | display | Qachon yoqiladi:
| |
| recommendation-high | Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Lipid spektri va qondagi kreatinin darajasi hamda koptokchali filtratsiya tezligi (KFT) hisobi reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta. | 0..1 | display | Qachon yoqiladi: cvd-risk-score >= 20 | |
| Ushbu format bo‘yicha hujjatlar | |||||
Variantlar to‘plamlari
sex uchun javob variantlari
tobacco-use uchun javob variantlari
cvd-risk-category uchun javob variantlari
FHIR
FHIRsmith{
"resourceType": "Questionnaire",
"id": "CVDRiskScreeningQuestionnaire",
"meta": {
"profile": [
"https://dhp.uz/fhir/core/StructureDefinition/uz-core-questionnaire|0.11.1"
]
},
"language": "uz",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "https://dhp.uz/fhir/integrations/Questionnaire/CVDRiskScreeningQuestionnaire",
"identifier": [
{
"system": "https://dhp.uz/fhir/core/sid/prg/uz/program",
"value": "300007000"
}
],
"version": "0.11.1",
"name": "CVDRiskScreeningQuestionnaire",
"title": "Yurak-qon tomir kasalliklari xavfini erta aniqlash skriningi",
"_title": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Скрининг раннего выявления риска сердечно-сосудистых заболеваний"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Cardiovascular disease risk screening"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"status": "draft",
"subjectType": [
"Patient"
],
"date": "2026-10-15T07:49:44+00:00",
"publisher": "Uzinfocom LLC",
"contact": [
{
"name": "Uzinfocom LLC",
"telecom": [
{
"system": "url",
"value": "https://uzinfocom.uz"
},
{
"system": "email",
"value": "info@uzinfocom.uz"
}
]
}
],
"description": "DMed qabulida bemor uchun so'rovnoma: yosh, jins, vazn, bo'y, TVI, arterial bosim va tamaki mahsulotlari iste'moli.",
"_description": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Опросник для DMed при приёме пациента: возраст, пол, вес, рост, ИМТ, артериальное давление и употребление табачных изделий."
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Questionnaire for DMed during patient visit: age, sex, weight, height, BMI, blood pressure and tobacco use."
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"useContext": [
{
"code": {
"system": "http://terminology.hl7.org/CodeSystem/usage-context-type",
"code": "program"
},
"valueCodeableConcept": {
"coding": [
{
"system": "https://terminology.dhp.uz/fhir/integrations/CodeSystem/integration-area-cs",
"code": "screening"
}
]
}
}
],
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "UZ",
"display": "Uzbekistan"
}
]
}
],
"code": [
{
"system": "http://snomed.info/sct",
"code": "300007000",
"display": "Screening for cardiovascular system disease",
"_display": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "uz"
},
{
"url": "content",
"valueString": "Yurak-qon tomir tizimi kasalliklari skriningi"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Скрининг заболеваний сердечно-сосудистой системы"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
],
"item": [
{
"linkId": "age",
"text": "Yosh",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Возраст"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Age"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "integer",
"required": true
},
{
"linkId": "sex",
"text": "Jins",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Пол"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Sex"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "coding",
"required": true,
"answerOption": [
{
"valueCoding": {
"system": "http://hl7.org/fhir/administrative-gender",
"code": "male",
"display": "Male",
"_display": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Мужской"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "uz"
},
{
"url": "content",
"valueString": "Erkak"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
},
{
"valueCoding": {
"system": "http://hl7.org/fhir/administrative-gender",
"code": "female",
"display": "Female",
"_display": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Женский"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "uz"
},
{
"url": "content",
"valueString": "Ayol"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
},
{
"valueCoding": {
"system": "http://hl7.org/fhir/administrative-gender",
"code": "other",
"display": "Other",
"_display": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Другой"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "uz"
},
{
"url": "content",
"valueString": "Boshqa"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
},
{
"valueCoding": {
"system": "http://hl7.org/fhir/administrative-gender",
"code": "unknown",
"display": "Unknown",
"_display": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Неизвестно"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "uz"
},
{
"url": "content",
"valueString": "Noma'lum"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
}
]
},
{
"linkId": "weight",
"text": "Vazn",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Вес"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Weight"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "decimal",
"required": true
},
{
"linkId": "height",
"text": "Bo'y",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Рост"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Height"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "decimal",
"required": true
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "weight",
"language": "text/fhirpath",
"expression": "%resource.item.where(linkId='weight').answer.value.ofType(decimal).first()"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "height",
"language": "text/fhirpath",
"expression": "%resource.item.where(linkId='height').answer.value.ofType(decimal).first()"
}
},
{
"url": "http://hl7.org/fhir/uv/sdc/StructureDefinition/sdc-questionnaire-calculatedExpression",
"valueExpression": {
"description": "BMI from weight and height",
"language": "text/fhirpath",
"expression": "iif(%height.exists() and %height > 0 and %weight.exists(), (%weight / ((%height / 100) * (%height / 100))).round(1), {})"
}
}
],
"linkId": "bmi",
"text": "Tana vazni indeksi",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Индекс массы тела"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Body mass index"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "decimal",
"readOnly": true
},
{
"linkId": "systolic-bp",
"text": "Sistolik bosim",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Систолическое давление"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Systolic blood pressure"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "decimal",
"required": true
},
{
"linkId": "diastolic-bp",
"text": "Diastolik bosim",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Диастолическое давление"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Diastolic blood pressure"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "decimal",
"required": true
},
{
"linkId": "tobacco-use",
"text": "Tamaki mahsulotlarini iste'mol qilish",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Употребление табачных изделий"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Tobacco products use"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "coding",
"required": true,
"answerOption": [
{
"valueCoding": {
"system": "http://snomed.info/sct",
"code": "702979003",
"display": "Never used tobacco",
"_display": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "uz"
},
{
"url": "content",
"valueString": "Iste'mol qilmaydi"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Не употребляет"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Does not use"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
},
{
"valueCoding": {
"system": "http://snomed.info/sct",
"code": "110483000",
"display": "Tobacco user",
"_display": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "uz"
},
{
"url": "content",
"valueString": "Iste'mol qiladi"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Употребляет"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Uses"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
},
{
"valueCoding": {
"system": "http://snomed.info/sct",
"code": "702975009",
"display": "Ex-tobacco user",
"_display": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "uz"
},
{
"url": "content",
"valueString": "Tashlagan"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Бросил"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Quit"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "weight",
"language": "text/fhirpath",
"expression": "%resource.item.where(linkId='weight').answer.value.ofType(decimal).first()"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "height",
"language": "text/fhirpath",
"expression": "%resource.item.where(linkId='height').answer.value.ofType(decimal).first()"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "age",
"language": "text/fhirpath",
"expression": "%resource.item.where(linkId='age').answer.value.ofType(integer).first()"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "sbp",
"language": "text/fhirpath",
"expression": "%resource.item.where(linkId='systolic-bp').answer.value.ofType(decimal).first()"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "sexcode",
"language": "text/fhirpath",
"expression": "%resource.item.where(linkId='sex').answer.value.ofType(Coding).code.first()"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "smk",
"language": "text/fhirpath",
"expression": "%resource.item.where(linkId='tobacco-use').answer.value.ofType(Coding).code.first()"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "bmi",
"language": "text/fhirpath",
"expression": "iif(%height.exists() and %height > 0 and %weight.exists(), %weight / ((%height / 100) * (%height / 100)), {})"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "ageIdx",
"language": "text/fhirpath",
"expression": "iif(%age < 45, 0, iif(%age < 50, 1, iif(%age < 55, 2, iif(%age < 60, 3, iif(%age < 65, 4, iif(%age < 70, 5, 6))))))"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "bmiIdx",
"language": "text/fhirpath",
"expression": "iif(%bmi < 20, 0, iif(%bmi < 25, 1, iif(%bmi < 30, 2, iif(%bmi < 36, 3, 4))))"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "sbpIdx",
"language": "text/fhirpath",
"expression": "iif(%sbp < 120, 0, iif(%sbp < 140, 1, iif(%sbp < 160, 2, iif(%sbp < 180, 3, 4))))"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "sexIdx",
"language": "text/fhirpath",
"expression": "iif(%sexcode = 'male', 0, iif(%sexcode = 'female', 1, {}))"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "smkIdx",
"language": "text/fhirpath",
"expression": "iif(%smk = '110483000', 1, 0)"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "idx",
"language": "text/fhirpath",
"expression": "((((%sexIdx * 2 + %smkIdx) * 7 + %ageIdx) * 5 + %sbpIdx) * 5 + %bmiIdx)"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "grid",
"language": "text/fhirpath",
"expression": "'01010202030202020304020303040504040507090607081114020202030302030304050404050608050608091208091214180203030405040405060705060709110809111317111316202504040606070506070911080911131611131619231519222732060708101108101113151214161922161922263123263136421011131517131618202318212427322528323742333742485416182023262224273033283135394337414550554751556267030304050604050608110608101317091115202614172330400304050709050709111408101316211215192632182329374706070910120709111418111317212716202531392429364454070911131611131619241518232634222632394731374453621113151822151821263021253035423035414855404754627016192225292225293439303439455140455157645158647177242730343832353944484145505560525762677364697479840101010102020202020302020303030304040505050506060701020202020202030304030304040504050506070707080912020203030303030404050405050607060707081009101112140303040404040505060706070708090910111214131416182105060607070708080909101011121313141517191819212326080910101111121314151516171820202123252626283032351415161718181920222323252628303032343638384043464803030404050404050606060708091010111214161516182124040405050606060708090809111214131416182019212325300606070809080910111212131416181719212326242630333708090911121112141517161719212422242730333134374145111214151615171921232224262931293235384239434650541718192123222426283130323437403942454852505357606424252729313133353840404245485150535559626164687174'"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/variable",
"valueExpression": {
"name": "pct",
"language": "text/fhirpath",
"expression": "iif(%age >= 40 and %age <= 74 and %sbp.exists() and %bmi.exists() and %sexIdx.exists() and %smk.exists(), %grid.substring(%idx * 2, 2).toInteger(), {})"
}
}
],
"linkId": "cvd-risk-result",
"text": "Yurak-qon tomir kasalliklari xavfini baholash",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Оценка риска сердечно-сосудистых заболеваний"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Cardiovascular disease risk assessment"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "group",
"item": [
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/sdc/StructureDefinition/sdc-questionnaire-calculatedExpression",
"valueExpression": {
"description": "WHO/ISH CVD 10-year risk percent looked up from the chart",
"language": "text/fhirpath",
"expression": "%pct"
}
}
],
"linkId": "cvd-risk-score",
"text": "10 yillik xavf (%)",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "10-летний риск (%)"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "10-year risk (%)"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "integer",
"readOnly": true
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/sdc/StructureDefinition/sdc-questionnaire-calculatedExpression",
"valueExpression": {
"description": "Risk band derived from the calculated risk percent",
"language": "text/fhirpath",
"expression": "iif(%pct.exists(), iif(%pct < 5, 'low', iif(%pct < 10, 'moderate', iif(%pct < 20, 'medium', iif(%pct < 30, 'high', 'very-high')))), {})"
}
}
],
"linkId": "cvd-risk-category",
"text": "Xavf darajasi",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Степень риска"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Risk level"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "coding",
"readOnly": true,
"answerOption": [
{
"valueCoding": {
"system": "https://terminology.dhp.uz/fhir/integrations/CodeSystem/cvd-risk-category-cs",
"code": "low",
"display": "Past xavf (<5%)",
"_display": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Низкий риск (<5%)"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Low risk (<5%)"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
},
{
"valueCoding": {
"system": "https://terminology.dhp.uz/fhir/integrations/CodeSystem/cvd-risk-category-cs",
"code": "moderate",
"display": "O'rtacha xavf (5% - <10%)",
"_display": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Умеренный риск (5% - <10%)"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Moderate risk (5% - <10%)"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
},
{
"valueCoding": {
"system": "https://terminology.dhp.uz/fhir/integrations/CodeSystem/cvd-risk-category-cs",
"code": "medium",
"display": "O'rtacha xavf (10% - <20%)",
"_display": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Средний риск (10% - <20%)"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Medium risk (10% - <20%)"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
},
{
"valueCoding": {
"system": "https://terminology.dhp.uz/fhir/integrations/CodeSystem/cvd-risk-category-cs",
"code": "high",
"display": "Yuqori xavf (20% - <30%)",
"_display": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Высокий риск (20% - <30%)"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "High risk (20% - <30%)"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
},
{
"valueCoding": {
"system": "https://terminology.dhp.uz/fhir/integrations/CodeSystem/cvd-risk-category-cs",
"code": "very-high",
"display": "Juda yuqori xavf (>=30%)",
"_display": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Очень высокий риск (>=30%)"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "Very high risk (>=30%)"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
}
]
},
{
"linkId": "recommendation-low",
"text": "Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv 12 oydan keyin o'tkaziladi.",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Рекомендуется здоровый образ жизни, правильное питание, физическая активность, ограничение употребления табака (если пациент употребляет табачные изделия), ограничение употребления алкоголя (если пациент употребляет алкоголь). Повторное обследование через 12 месяцев."
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "A healthy lifestyle, proper nutrition, physical activity, reduced tobacco use (if the patient uses tobacco products) and limited alcohol consumption (if the patient drinks alcohol) are recommended. Repeat assessment after 12 months."
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "display",
"enableWhen": [
{
"question": "cvd-risk-score",
"operator": "<",
"answerInteger": 5
}
]
},
{
"linkId": "recommendation-moderate",
"text": "Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv har uch oyda o'tkaziladi (arterial bosimning maqsadli darajasiga erishilganda - takroriy tekshiruvlar har 6-9 oyda amalga oshiriladi). Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'zlar ko'ruvi, EKG - 2 yilda 1 marta yoki ko'rsatma bo'yicha.",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Рекомендуется здоровый образ жизни, правильное питание, физическая активность, ограничение употребления табака (если пациент употребляет табачные изделия), ограничение употребления алкоголя (если пациент употребляет алкоголь). Повторные обследования каждые 3 месяца (при достижении артериального давления целевого уровня - повторные обследования каждые 6-9 месяцев). Мониторинг глюкозы в крови, холестерина, белка мочи, осмотр глаз, ЭКГ - 1 раз в 2 года или по назначению."
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "A healthy lifestyle, proper nutrition, physical activity, reduced tobacco use (if the patient uses tobacco products) and limited alcohol consumption (if the patient drinks alcohol) are recommended. Repeat assessment every 3 months (once the blood pressure target is reached - every 6-9 months). Monitoring of blood glucose, cholesterol and urine protein, eye examination and ECG - once every 2 years or as prescribed."
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "display",
"enableWhen": [
{
"question": "cvd-risk-score",
"operator": ">=",
"answerInteger": 5
},
{
"question": "cvd-risk-score",
"operator": "<",
"answerInteger": 10
}
],
"enableBehavior": "all"
},
{
"linkId": "recommendation-medium",
"text": "Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta.",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Рекомендуется здоровый образ жизни, правильное питание, физическая активность, ограничение употребления табака (если пациент употребляет табачные изделия), ограничение употребления алкоголя (если пациент употребляет алкоголь). Мониторинг каждые 3-6 месяцев до достижения целевого уровня артериального давления. Мониторинг глюкозы в крови, холестерина, белка мочи, исследование глазного дна, ЭКГ - 1 раз в год по плану или по назначению. Осмотр кардиолога, терапевта плановый 1 раз в год или по назначению."
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "A healthy lifestyle, proper nutrition, physical activity, reduced tobacco use (if the patient uses tobacco products) and limited alcohol consumption (if the patient drinks alcohol) are recommended. Monitoring every 3-6 months until the blood pressure target is reached. Monitoring of blood glucose, cholesterol and urine protein, fundus examination and ECG - once a year as scheduled or as prescribed. Cardiologist and general practitioner review - once a year as scheduled or as prescribed."
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "display",
"enableWhen": [
{
"question": "cvd-risk-score",
"operator": ">=",
"answerInteger": 10
},
{
"question": "cvd-risk-score",
"operator": "<",
"answerInteger": 20
}
],
"enableBehavior": "all"
},
{
"linkId": "recommendation-high",
"text": "Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Lipid spektri va qondagi kreatinin darajasi hamda koptokchali filtratsiya tezligi (KFT) hisobi reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta.",
"_text": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "ru"
},
{
"url": "content",
"valueString": "Рекомендуется здоровый образ жизни, правильное питание, физическая активность, ограничение употребления табака (если пациент употребляет табачные изделия), ограничение употребления алкоголя (если пациент употребляет алкоголь). Мониторинг каждые 3-6 месяцев до достижения целевого уровня артериального давления. Мониторинг глюкозы в крови, холестерина, белка мочи, исследование глазного дна, ЭКГ - 1 раз в год по плану или по назначению. Определение липидного спектра и уровня креатинина в крови и расчёт скорости клубочковой фильтрации (СКФ) 1 раз в год в плановом порядке или по назначению. Осмотр кардиолога, терапевта - плановый 1 раз в год или по назначению."
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
},
{
"extension": [
{
"url": "lang",
"valueCode": "en"
},
{
"url": "content",
"valueString": "A healthy lifestyle, proper nutrition, physical activity, reduced tobacco use (if the patient uses tobacco products) and limited alcohol consumption (if the patient drinks alcohol) are recommended. Monitoring every 3-6 months until the blood pressure target is reached. Monitoring of blood glucose, cholesterol and urine protein, fundus examination and ECG - once a year as scheduled or as prescribed. Lipid profile, blood creatinine and glomerular filtration rate (GFR) calculation - once a year as scheduled or as prescribed. Cardiologist and general practitioner review - once a year as scheduled or as prescribed."
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"type": "display",
"enableWhen": [
{
"question": "cvd-risk-score",
"operator": ">=",
"answerInteger": 20
}
]
}
]
}
]
}